Document is current
Any future updates will be listed below
-
Authors
Haysen, Stine Rabech
Nielsen, Ane Langkilde-Lauesen
Qvist, Per
Kragstrup, Tue Wenzel https://orcid.org/0000-0002-6439-397X
-
Funding
Funding for this research was provided by:
Aarhus Universitet
- License Information
-
More Information
Article History
Received: 13 September 2024
Accepted: 31 January 2025
First Online: 24 February 2025
Declarations
:
: TWK: speaking fees from Pfizer, Bristol-Myers Squibb, Eli Lilly, Novartis, UCB, and Abbvie. Consultancy fees from Bristol-Myers Squibb, UCB, Gilead, and Eli-Lilly. Research grants from Gilead. Co-founder and clinical developer in Aptol Pharma.
: Not applicable.
